These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35595612)
1. Treatment Patterns in Women Age 80 and Over With DCIS: A Report From the National Cancer Database. Frebault J; Bergom C; Cortina CS; Shukla ME; Zhang Y; Huang CC; Kong AL Clin Breast Cancer; 2022 Aug; 22(6):547-552. PubMed ID: 35595612 [TBL] [Abstract][Full Text] [Related]
2. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS. Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A; Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934 [TBL] [Abstract][Full Text] [Related]
3. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study. Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099 [TBL] [Abstract][Full Text] [Related]
4. Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males. Carter MM; Whitrock JN; Pratt CG; Shaughnessy EA; Meier TM; Barrord MF; Hanseman DJ; Reyna CR; Heelan AA; Lewis JD Ann Surg Oncol; 2024 Mar; 31(3):1599-1607. PubMed ID: 37978114 [TBL] [Abstract][Full Text] [Related]
5. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery. Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557 [TBL] [Abstract][Full Text] [Related]
6. Trends in Unilateral and Contralateral Prophylactic Mastectomy Use in Ductal Carcinoma In Situ of the Breast: Patterns and Predictors. Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC; Oseni TO Ann Surg Oncol; 2019 Nov; 26(12):3863-3873. PubMed ID: 31325048 [TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study. Nguyen TT; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC Ann Surg Oncol; 2017 Oct; 24(10):2989-2998. PubMed ID: 28766214 [TBL] [Abstract][Full Text] [Related]
8. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164 [TBL] [Abstract][Full Text] [Related]
9. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193 [TBL] [Abstract][Full Text] [Related]
10. Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. Frebault J; Bergom C; Cortina CS; Shukla ME; Zhang Y; Huang CC; Kong AL Clin Breast Cancer; 2022 Jan; 22(1):49-59. PubMed ID: 34391660 [TBL] [Abstract][Full Text] [Related]
11. Breast-Conserving Surgery in Patients With Mammary Paget's Disease. Yao Y; Sun L; Meng Y; Zhuang Y; Zhao L; Yu Q; Si C J Surg Res; 2019 Sep; 241():178-187. PubMed ID: 31026796 [TBL] [Abstract][Full Text] [Related]
13. Contralateral breast cancer after curative-intent treatment for ductal carcinoma in situ: Rate and associated clinicopathological and imaging risk factors. Hovis K; Mercaldo S; Kim G; Lamb LR; Oseni TO; Bahl M Clin Imaging; 2022 Feb; 82():179-192. PubMed ID: 34872008 [TBL] [Abstract][Full Text] [Related]
14. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038 [TBL] [Abstract][Full Text] [Related]
15. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery. Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071 [TBL] [Abstract][Full Text] [Related]
16. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer. Choi YJ; Shin YD; Song YJ World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132 [TBL] [Abstract][Full Text] [Related]
17. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Greenberg CC; Habel LA; Hughes ME; Nekhlyudov L; Achacoso N; Acton L; Schrag D; Jiang W; Edge S; Weeks JC; Punglia RS Ann Surg Oncol; 2014 Nov; 21(12):3766-73. PubMed ID: 24859938 [TBL] [Abstract][Full Text] [Related]
18. Trends in the treatment of ductal carcinoma in situ of the breast. Baxter NN; Virnig BA; Durham SB; Tuttle TM J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469 [TBL] [Abstract][Full Text] [Related]
19. Ductal Carcinoma In Situ - Quo Vadis? Peltecu G Chirurgia (Bucur); 2021 Dec; 116(5 Suppl):S5-S6. PubMed ID: 34967322 [TBL] [Abstract][Full Text] [Related]
20. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. Giannakeas V; Sopik V; Narod SA JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]